Yan, W., Du, C., Lv, R., Zou, H., Zhang, S., Yu, T., Yan, Y., Zhang, Y., Peng, S., Wang, T., Deng, S., Huang, W., Yi, S., Zou, D., Cheng, T., Wang, J., Chang, A. H., Qiu, L., An, G. (2026). Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001). Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01969